Farrow Jeffrey S's Form 4 filing
Tarsus Pharmaceuticals, Inc. (TARS) · filed Mar 19, 2026
- Accession no.
- 0001405253-26-000007
- Filed
- Mar 19, 2026
- Trade date
- Mar 17-19, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $439.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Farrow Jeffrey SCIK 0001405253 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Common Stock | SSaleDisposed | −2,111 | $69.42 | −$146,545.62 | 47,635 | Direct | |
| Mar 18, 2026 | Common Stock | SSaleDisposed | −2,133 | $68.71 | −$146,558.43 | 45,502 | Direct | |
| Mar 19, 2026 | Common Stock | SSaleDisposed | −2,186 | $67.00 | −$146,462 | 43,316 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.